Über diese Zeitschrift
Dermatology and Therapy is focused on cutting-edge research, treatment, and aesthetic interventions in dermatology. Emphasis is placed on articles that investigate the clinical aspects of dermatology, such as skin pharmacology; skin development and aging, prevention, diagnosis, and management of skin disorders; and research into dermal structures and pathology. Articles relating to diagnosis, pharmacoeconomics, outcomes, patient care, management, education, and quality of life are also encouraged. The journal is fully open access, internationally peer-reviewed and offers rapid publication (peer review within 2 week, online 3-4 weeks from acceptance).
The journal is of interest to a broad audience of pharmaceutical and healthcare professionals and publishes original research papers, drug reviews, case reports, and short communications.
Dermatology and Therapy offers a range of additional features designed to enhance the educational content of the research. Each article is accompanied by a bulleted slide summary for a time-efficient overview of the content. Articles also have the option to include various other types of enhanced features including slide sets, videos and animations. These features are published alongside the article on the bespoke journal website: www.dermtherapy-open.com
Upon acceptance of your article for publication, you will be required to pay the article open access fee of £230/$360 per printed page. This will enable you to keep the copyright; you are simply assigning the exclusive right to any commercial use of the article to Springer. Your article will be immediately and permanently available with open access.
Dermatology and Therapy is published under the Creative Commons Attribution-Noncommercial License, which allows users to read, copy, distribute, and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited. The author assigns the exclusive right to any commercial use of the article to Springer.
For more information about the Creative Commons Attribution-Noncommercial License, click here: http://creativecommons.org/licenses/by-nc/4.0